文献速递产科

氨甲环酸预防择期再次剖宫产产后出血的随机研究

Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery-a randomized study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-01-15

该双盲随机安慰剂对照试验纳入110例≥37周单胎、拟在椎管内麻醉下行第二次或第三次剖宫产的孕妇,比较预防性氨甲环酸1g(切皮前及胎盘娩出后各一次)与安慰剂对24小时计算失血量的影响。氨甲环酸组平均计算失血量2274±469 mL,安慰剂组2407±388 mL(P>.05);氨甲环酸组D-二聚体水平低于安慰剂组(2.1±1.2 µg/mL vs 4.3±2.4 µg/mL,P<.001)。结论为预防性氨甲环酸未降低平均计算失血量。

要点

  • 择期再次剖宫产预防性氨甲环酸1g未降低24小时平均计算失血量(2274±469 mL vs 2407±388 mL,P>.05)。
  • 氨甲环酸组24小时D-二聚体低于安慰剂组(2.1±1.2 µg/mL vs 4.3±2.4 µg/mL,P<.001)。
  • 美国妇产科医师学会指出当前数据不足以推荐氨甲环酸用于产后出血预防。

核心结论

  • 预防性氨甲环酸治疗未降低择期再次剖宫产产妇的平均计算失血量。
  • 氨甲环酸组计算失血量>2000 mL的参与者显著少于安慰剂组,且24小时D-二聚体水平更低。

研究设计与样本

  • 双盲、随机、安慰剂对照试验,纳入≥37周单胎妊娠、在椎管内麻醉下接受第二次或第三次剖宫产的孕妇。
  • 于切皮前及胎盘娩出后给予预防性氨甲环酸1 g(联合标准宫缩剂),对照组给予安慰剂。
  • 主要结局为24小时计算失血量,基于身高、体重及术前与产后24小时血细胞比容差值计算。
  • 计划每组50例(N=100),实际筛查723例,随机110例:氨甲环酸组55例,安慰剂组55例。

主要发现

  • 主要结局平均计算失血量:氨甲环酸组2274±469 mL,安慰剂组2407±388 mL(P>.05)。
  • 次要结局:产后24小时D-二聚体水平氨甲环酸组2.1±1.2 µg/mL,安慰剂组4.3±2.4 µg/mL(P<.001)。
  • 氨甲环酸组计算失血量>2000 mL的参与者显著少于安慰剂组。

关键数值与推荐

  • 美国妇产科医师学会指出当前数据不足以推荐氨甲环酸用于产后出血预防。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American College of Obstetricians and Gynecologists states that the current data are insufficient to recommend tranexamic acid prophylaxis for postpartum hemorrhage. OBJECTIVE: This study's objective was to evaluate if prophylactic tranexamic acid treatment reduces the calculated blood loss when compared with a placebo in women undergoing an elective repeat cesarean delivery. STUDY DESIGN: This was a double-blind, randomized, placebo-controlled trial in which the calculated blood loss was determined after administration of prophylactic doses of 1 g of tranexamic acid before skin incision and after placental delivery and standard uterotonics in women with singleton pregnancies at ≥37 weeks' gestation presenting for their second or third cesarean delivery under neuraxial anesthesia. The primary outcome was calculated blood loss at 24 hours. The calculation was based on each participant's height, weight, and the difference in hematocrit before the start of surgery and 24 hours after delivery. Prespecified secondary outcomes were quantification of maternal coagulation activity during the perioperative course. A sample size of 50 women per group was planned (N=100) based on a meta-analysis of mean reduction in blood loss after tranexamic acid. RESULTS: A total of 723 women were screened, and 110 women were randomized as follows: 55 to the tranexamic acid group and 55 to the placebo group. The primary outcome of mean calculated blood loss was 2274±469 mL for the tranexamic acid group and 2407±388 mL for the placebo group (P>.05). For the secondary outcomes, D-dimer levels were lower in the tranexamic acid group than in the placebo group 24 hours after delivery (2.1±1.2 µg/mL vs 4.3±2.4 µg/mL; P<.001). CONCLUSION: Prophylactic tranexamic acid treatment did not decrease the mean calculated blood loss. Significantly less participants had a calculated blood loss >2000 mL in the tranexamic acid group than in the placebo group and had lower levels of D-dimer at 24 hours.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Ogunkua OT, Duryea EL, Nelson DB, et al. Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery-a randomized study. Am J Obstet Gynecol MFM. 2022. PMID: 35038612. doi:10.1016/j.ajogmf.2022.100573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。